Skip to content
MarketScale
‹ Back to IndustriesHealthcare

As Omicron Variant Spreads, At-Home Tests May Not Be Home for the Holidays

Omicron is the word on everyone’s tongues this holiday season, as the latest COVID-19 variant is surging just as the country enters peak travel dates. Already, airports have seen the most traffic since before the pandemic. The Biden administration has implemented testing requirements, regardless of vaccination status, to all international travelers to help curb the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Omicron is the word on everyone’s tongues this holiday season, as the latest COVID-19 variant is surging just as the country enters peak travel dates. Already, airports have seen the most traffic since before the pandemic. The Biden administration has implemented testing requirements, regardless of vaccination status, to all international travelers to help curb the spread. At-home tests have fast become a popular way for people to check their COVID-status, and the industry is having to adjust quickly as variants develop.

According to Gerald Commissiong, the Chief Executive Officer of Todos Medical, some at-home tests have already been rendered ineffective as the already-existent variants have changed the sequences in the virus.

“We need to start thinking about a completely new set of tests that are able to detect different parts of the virus that do not mutate,” said Commissiong.

Todos Medical is working on their own 3CL protease test that wouldn’t rely on the ever-changing sequence of the virus to detect it.

“That may be a solution to get around a mutating virus,” he said.

Another challenge during the holiday season regarding at-home tests is the delayed delivery times for packages, which could render a test potentially useless if the tested individual later encountered someone with the virus, or if the integrity of the test degraded during the shipping process. He says increasing the number of local labs is a workaround for this situation to help lessen delivery time. Commissiong spoke highly of the vaccines, though stressed that they are designed to prevent hospitalization and death.

“If you get sick, you’re less likely to have a severe disease and potentially less likely to get long COVID,” said Commissiong.

He called this “a call to action,” considering many people who have had the virus have dealt with extended issues tasting, smelling, brain fog and even worse symptoms. Commissiong spoke of the necessity to develop a strategy in how to implement rapid tests. Without such a strategy in place, he recommends the PCR test for the holiday,

“The PCR test is really the best test if you are going to go and see people and are worried you could be carrying the disease,” said Commissiong.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

In the first half of 2026, digital health AI investments reached $7.4 billion as organizations like CMS, hospitals, and startups increased their adoption of AI. Significant moves include the establishment of a new CMS technology office and a $1.7 billion acquisition in cancer technology. These developments mark an enterprise-level commitment to advancing AI in healthcare.

  • 01Digital health AI investments reached $7.4 billion in H1 2026.
  • 02The CMS established a new technology office to advance healthcare AI.
  • 03A major acquisition in cancer technology totaled $1.7 billion.

Jul 30, 2026

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

The global structural health monitoring (SHM) market is projected to surpass $8.6 billion by 2035. This growth is fueled by the integration of AI analytics, wireless sensor technologies, and the necessity to address aging infrastructure. The expansion reflects a widespread adoption of these technologies in various sectors.

  • 01The SHM market is expected to exceed $8.6 billion by 2035.
  • 02Advancements in AI-powered analytics and wireless sensors are key drivers of market growth.
  • 03Aging infrastructure is creating a demand for enhanced structural health monitoring solutions.

Jul 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512